672 related articles for article (PubMed ID: 28606651)
1. Mechanisms of bile acid mediated inflammation in the liver.
Li M; Cai SY; Boyer JL
Mol Aspects Med; 2017 Aug; 56():45-53. PubMed ID: 28606651
[TBL] [Abstract][Full Text] [Related]
2. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
3. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.
Allen K; Jaeschke H; Copple BL
Am J Pathol; 2011 Jan; 178(1):175-86. PubMed ID: 21224055
[TBL] [Abstract][Full Text] [Related]
4. Bile Acids in Cholestasis and its Treatment.
Arab JP; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
[TBL] [Abstract][Full Text] [Related]
5. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.
O'Brien KM; Allen KM; Rockwell CE; Towery K; Luyendyk JP; Copple BL
Am J Pathol; 2013 Nov; 183(5):1498-1507. PubMed ID: 24012680
[TBL] [Abstract][Full Text] [Related]
6. Inflammation Drives MicroRNAs to Limit Hepatocyte Bile Acid Transport in Murine Biliary Atresia.
Azeltine MW; Chavez EJ; Nemec KM; Bednarek JM; Asokan R; Balasubramaniyan N; Zgheib C; Mack CL; Roach JP
J Surg Res; 2020 Dec; 256():663-672. PubMed ID: 32818799
[TBL] [Abstract][Full Text] [Related]
7. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
[TBL] [Abstract][Full Text] [Related]
8. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
9. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.
Cai SY; Ouyang X; Chen Y; Soroka CJ; Wang J; Mennone A; Wang Y; Mehal WZ; Jain D; Boyer JL
JCI Insight; 2017 Mar; 2(5):e90780. PubMed ID: 28289714
[TBL] [Abstract][Full Text] [Related]
10. Bile acids and their receptors during liver regeneration: "Dangerous protectors".
Merlen G; Ursic-Bedoya J; Jourdainne V; Kahale N; Glenisson M; Doignon I; Rainteau D; Tordjmann T
Mol Aspects Med; 2017 Aug; 56():25-33. PubMed ID: 28302491
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targets for cholestatic liver injury.
Woolbright BL; Jaeschke H
Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
[TBL] [Abstract][Full Text] [Related]
12. Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice.
Woolbright BL; Li F; Xie Y; Farhood A; Fickert P; Trauner M; Jaeschke H
Toxicol Lett; 2014 Jul; 228(1):56-66. PubMed ID: 24742700
[TBL] [Abstract][Full Text] [Related]
13. Novel insight into mechanisms of cholestatic liver injury.
Woolbright BL; Jaeschke H
World J Gastroenterol; 2012 Sep; 18(36):4985-93. PubMed ID: 23049206
[TBL] [Abstract][Full Text] [Related]
14. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
15. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance of hepatocyte retinoid X receptor alpha-null mice to WY-14,643-induced hepatocyte proliferation and cholestasis.
Gyamfi MA; Wan YJ
J Biol Chem; 2009 Apr; 284(14):9321-30. PubMed ID: 19176532
[TBL] [Abstract][Full Text] [Related]
18. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
Verhaag EM; Buist-Homan M; Koehorst M; Groen AK; Moshage H; Faber KN
PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211
[TBL] [Abstract][Full Text] [Related]
19. Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling.
Zhang L; Pan Q; Zhang L; Xia H; Liao J; Zhang X; Zhao N; Xie Q; Liao M; Tan Y; Li Q; Zhu J; Li L; Fan S; Li J; Zhang C; Cai SY; Boyer JL; Chai J
Hepatology; 2023 Jun; 77(6):1866-1881. PubMed ID: 36647589
[TBL] [Abstract][Full Text] [Related]
20. Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.
Yang QL; Yang F; Gong JT; Tang XW; Wang GY; Wang ZT; Yang L
Acta Pharmacol Sin; 2016 Sep; 37(9):1218-28. PubMed ID: 27498779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]